Morgan Stanley Knock-Out MRK/ DE000MB90FY8 /
2024-05-22 1:58:23 PM | Chg.-0.08 | Bid2:43:07 PM | Ask2:43:07 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
2.96EUR | -2.63% | 2.99 Bid Size: 20,000 |
3.00 Ask Size: 20,000 |
MERCK KGAA O.N. | 136.2546 EUR | 2078-12-31 | Call |
GlobeNewswire
1:00 PM
Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual...
GlobeNewswire
05-07
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
05-06
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA